DECA - Clinical Trials Branch

A new study spearheaded by investigators at Scripps Research and the National Eye Institute offers compelling evidence that vision loss from macular telangiectasia can be slowed with a neuroprotective surgical implant.

A longstanding member of the NEI/NIH community, Emily Chew, M.D., has been promoted to the title of NIH Distinguished Investigator for her tireless and prolific work as a care provider and clinical trialist.

Tiarnan Keenan, NEI Division of Epidemiology and Clinical Applications, and colleagues found that people with age-related macular degeneration (AMD) can successfully use the Notal Home OCT device to monitor their disease.